317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors

317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors

Bibliographic Details
Main Authors: Leisha Emens, Naomi Hunder, Samuel Klempner, Erika Hamilton, Muralidhar Beeram, Valerie Odegard, Sue Hamke
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-4272e96afa7b43f48918d978722ad719
record_format Article
spelling doaj-4272e96afa7b43f48918d978722ad7192020-12-11T10:01:25ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0317317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumorsLeisha Emens0Naomi Hunder1Samuel Klempner2Erika Hamilton3Muralidhar Beeram4Valerie Odegard5Sue Hamke6Aff501 grid.21107.350000000121719311Johns Hopkins University School of Medicine Baltimore MD USA Aff12 grid.419971.3Formerly of ZymoGenetics (Bristol-Myers Squibb) Seattle WA USA 1Massachusetts General Hospital, Boston, MA, USA3Sarah Cannon Research Institute, Nashville, TN, USA2The Start Center for Cancer Care, San Antonio, TX, USA5Silverback Therapeutics, Inc., Seattle, WA, USA5Silverback Therapeutics, Inc., Seattle, WA, USA
collection DOAJ
language English
format Article
sources DOAJ
author Leisha Emens
Naomi Hunder
Samuel Klempner
Erika Hamilton
Muralidhar Beeram
Valerie Odegard
Sue Hamke
spellingShingle Leisha Emens
Naomi Hunder
Samuel Klempner
Erika Hamilton
Muralidhar Beeram
Valerie Odegard
Sue Hamke
317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
Journal for ImmunoTherapy of Cancer
author_facet Leisha Emens
Naomi Hunder
Samuel Klempner
Erika Hamilton
Muralidhar Beeram
Valerie Odegard
Sue Hamke
author_sort Leisha Emens
title 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
title_short 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
title_full 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
title_fullStr 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
title_full_unstemmed 317 A phase 1/1b study of SBT6050, a HER2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced HER2-expressing solid tumors
title_sort 317 a phase 1/1b study of sbt6050, a her2-directed monoclonal antibody conjugated to a toll-like receptor 8 agonist, in subjects with advanced her2-expressing solid tumors
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT leishaemens 317aphase11bstudyofsbt6050aher2directedmonoclonalantibodyconjugatedtoatolllikereceptor8agonistinsubjectswithadvancedher2expressingsolidtumors
AT naomihunder 317aphase11bstudyofsbt6050aher2directedmonoclonalantibodyconjugatedtoatolllikereceptor8agonistinsubjectswithadvancedher2expressingsolidtumors
AT samuelklempner 317aphase11bstudyofsbt6050aher2directedmonoclonalantibodyconjugatedtoatolllikereceptor8agonistinsubjectswithadvancedher2expressingsolidtumors
AT erikahamilton 317aphase11bstudyofsbt6050aher2directedmonoclonalantibodyconjugatedtoatolllikereceptor8agonistinsubjectswithadvancedher2expressingsolidtumors
AT muralidharbeeram 317aphase11bstudyofsbt6050aher2directedmonoclonalantibodyconjugatedtoatolllikereceptor8agonistinsubjectswithadvancedher2expressingsolidtumors
AT valerieodegard 317aphase11bstudyofsbt6050aher2directedmonoclonalantibodyconjugatedtoatolllikereceptor8agonistinsubjectswithadvancedher2expressingsolidtumors
AT suehamke 317aphase11bstudyofsbt6050aher2directedmonoclonalantibodyconjugatedtoatolllikereceptor8agonistinsubjectswithadvancedher2expressingsolidtumors
_version_ 1724386651782774784

Similar Items